| NDC Code | 0003-6120-01 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-6120-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 0003-6120 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Opdivo Qvantig |
|---|
| Non-Proprietary Name | Nivolumab And Hyaluronidase-nvhy |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | SUBCUTANEOUS |
|---|
| Start Marketing Date | 20250102 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761381 |
|---|
| Manufacturer | E.R. Squibb & Sons, L.L.C. |
|---|
| Substance Name | HYALURONIDASE (HUMAN RECOMBINANT); NIVOLUMAB |
|---|
| Strength | 2000; 120 |
|---|
| Strength Unit | U/mL; mg/mL |
|---|
| Pharmacy Classes | Endoglycosidase [EPC], Glycoside Hydrolases [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA] |
|---|